Story perspectives

Trump Faces Pressure to Expedite Mifepristone Review

12/22/2025

50 4

Summary

Story summary

Anti-abortion advocates press U.S. President Donald Trump's administration to expedite FDA review of mifepristone, approved since 2000.
Promises from FDA Commissioner Marty Makary that the review would proceed have not materialized; conservatives call for his dismissal.
Senate Committee Chair Bill Cassidy and former Vice President Mike Pence demand transparency on mifepristone's safety, while some view Trump's states-rights approach as political protection.

1 of 1

Story summary

Anti-abortion advocates press U.S. President Donald Trump's administration to expedite FDA review of mifepristone, approved since 2000.
Promises from FDA Commissioner Marty Makary that the review would proceed have not materialized; conservatives call for his dismissal.
Senate Committee Chair Bill Cassidy and former Vice President Mike Pence demand transparency on mifepristone's safety, while some view Trump's states-rights approach as political protection.